We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Evelo Biosciences

News List

Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 Trial americanpharmaceuticalreview
July 01, 2020
Evelo Biosciences announced EDP1815 will be included in the TACTIC-E clinical trial.
Evelo Announces Patent Covering Use of Proprietary Bifidobacterium animalis ssp. lactis Strain americanpharmaceuticalreview
March 06, 2020
Evelo Biosciences announced the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,576,111, entitled “Method of treating cancer using Bifidobacterium animalis ssp.
Evelo Biosciences, Mayo Clinic Announce Collaboration americanpharmaceuticacreview
November 17, 2017
Evelo Biosciences announced a collaboration with Mayo Clinic to develop and commercialize monoclonal microbials for the treatment of inflammatory and neuroinflammatory diseases.